FREQ - Frequency Therapeutics Inc
Close
0.2996
0.017 5.607%
Share volume: 309,164
Last Updated: Fri 03 Nov 2023 09:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.28
0.02
5.94%
Fundamental analysis
14%
Profitability
3%
Dept financing
38%
Liquidity
41%
Performance
12%
Performance
5 Days
29.14%
1 Month
-2.12%
3 Months
-58.68%
6 Months
-25.62%
1 Year
-87.52%
2 Year
-95.67%
Key data
Stock price
$0.30
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.18 - $5.59
52 WEEK CHANGE
-$0.88
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website: frequencytx.com
Employees: 66
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
Region: US
Website: frequencytx.com
Employees: 66
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the complexity of genetic engineering. our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the u.s. alone.
Recent news